The dosimetric stability of six TomoTherapy units was analyzed to investigate changes in performance over time and with system upgrades. Energy and output were tracked using monitor chamber signal, onboard megavoltage computed tomography (MVCT) detector profile, and external ion chamber measurements. The systems (and monitoring periods) include three Hi-Art (67, 61, and 65 mos.), two TomoHDA (31 and 26 mos.), and one Radixact unit (11 mos.), representing approximately 10 years of clinical use.
| INTRODUCTION
TomoTherapy is a helical radiation therapy delivery system developed at the University of Wisconsin To add to this body of work, we report on the energy and output stability of multiple TomoTherapy systems of different generations including a DCS/FTL system operating at a higher dose rate. The objective of this paper is to examine the dosimetric stability of six different TomoTherapy units over the lifetime of this technology. Changes in performance over time, and with system upgrades, are presented.
| ME TH ODS
Energy and output were tracked using monitor chamber signal, onboard MVCT detector signal, and external ion chamber measure- The output stability is reported as deviation from reference monitor chamber signal for all systems, and from external ion chamber measurements for four systems. The energy stability was monitored using the relative (center versus off-axis) MVCT detector profiles and/or the ratio of chamber measurements at two depths (PDD ratio). Re-baselining of expected values following machine service was only performed after independent validation of a given metric (output or energy) with an ion chamber measurement. Additional ion chamber measurements were used to investigate the output stability of the RF chain over extended treatment deliveries on an TomoHDA and Radixact system.
2.A | Internal monitor chamber and exit detector data
The internal monitor chamber and MVCT detector signals were used to assess output and energy stability, respectively. Of the two monitor chambers, only the primary monitor chamber signal (dose1) was used for this study. The monitor chamber data and exit detector data were manually processed using MATLAB TM . The monitor chamber output signal is reported as a difference from the average signal over the monitoring period. The extensive monitor chamber data archives included data generated prior to, and during, field service measurements. Therefore, monitor chamber signal analysis was limited to the data that were within AE3% of the average, since larger variations were from the machine being run under nonclinical delivery conditions. In addition to the monitor chamber analysis, the daily output on all machines was verified on all clinical days to be within AE3% of the baseline in accordance with AAPM guidelines 9 .
To evaluate beam energy, the exit detector central channels (80-570) were extracted from each 200 s RotVar. The normalized ratio was then computed using the first dataset as a reference. The average Root Mean Square (RMS) across each channel of the normalized ratio was then computed and reported for each run.
For the TomoHDA and Radixact, the same monitor chamber and lateral profile at the exit detector was acquired using vendor-supplied diagnostics and analysis software, TomoTherapy Quality Assurance (TQA) 10 . The TQA software offers various modules to capture and analyze machine data. The "Daily QA" module is a 5-min rotational procedure consisting of several tests, one of which approximates the J48 RotVar. The monitor chamber data and output ratio (relative to the calibrated baseline value) and RMS of the exit detector channels relative to baseline values are acquired and computed by the TQA software. These data were captured on each clinical day as part of morning QA.
2.B | Ion chamber measurements
Ion chamber measurements were taken in Solid Water 
2.C | Service records
Major service upgrades relating to dosimetric stability were tallied for the delivery systems in this study. Magnetron, linac, and target replacements were considered dosimetrically significant. Routine work (e.g., addition of dielectric gas), MLC system work, and mechanical repairs were not recorded. Complete service records were available for the TomoHDA and Radixact systems. The service history for the Hi-Art systems was assembled from paper records in Table 1 and with the service data in Table 5 .
| RESULTS
As expected, the stability of the daily output has significantly improved with DCS. The standard deviation (r) of the output for non-DCS systems was less than 2%, and for DCS system was less than 1%. The percent of readings within 2r is greater than 90% for all units. This result is supported by both ion chamber measurements and monitor chamber analysis. The results for all six systems are summarized in Table 2 . Figures 2 and 3 are histograms of the output for non-DCS and DCS systems, respectively, baselined at 100%. The output was tracked for over 60 months for each non-DCS and over 30 months for the DCS systems. The effect of DCS is apparent in that the daily output ranged from AE3% in the older systems, and the introduction of DCS decreased the daily variation to less than 1%.
The Radixact data were not included in Fig. 3 because of the limited data history available as compared to the other systems.
Energy stability also improved with the FTL and DCS. As shown in Table 3 , the average RMS flatness value for rotating target systems ranged from 0.23% to 0.62%, while for fixed target systems the RMS flatness ranged from 0.04% to 0.09%. This difference is also illustrated in Fig. 4 , where the normalized exit detector ratio is plotted over all datasets for a rotating target system (SN 04) and a fixed target system (SN 103). As a rotating target thins, the energy decreases and becomes more forward peaked, causing the shoulders of the exit detector ratio to drop 11 . The Radixact system appears to be as stable as the TomoHDA systems when considering RMS flatness. The average ion chamber PDD 20/10 ratio difference yielded similar variation in energy stability over time. However, the improved energy stability with the fixed target observed with the exit detector data is not appreciated with the ion chamber PDD 20/10 ratio due to lack of statistical power. The cone ratio data is the key driver in concluding the energy has improved with the FTL, as illustrated in Table 4 . The CoV of the output at both depths (10 cm and 20 cm) was less than 0.2%, which is to be expected as both systems are using DCS. The CoV of T A B L E 2 Output stability. The standard deviation of output and (% within 2r of mean) for all machines for which the data was available. An A1SL was used as an external ion chamber to measure output in solid water phantom. The monitor chamber signal is from the primary internal chamber (dose1). 
Relative output for non-DCS systems measured by the monitor chamber. Data for days on which the machine was being serviced or otherwise out of the daily AE3% tolerance (and therefore not acceptable for treatment) are not included.
Relative output for DCS systems measured by the monitor chamber. Data for days on which the machine was being serviced or otherwise out of the daily AE3% tolerance (and therefore not acceptable for treatment) are not included.
T A B L E 3 Energy stability. The mean and (number of data points) of exit detector RMS flatness and PDD 20/10 ratio for all machines. (67) the ratios of the 60 s averaged readings at the two depths demonstrate the energy stability during these extended deliveries.
The service records from the machines are summarized in Table 5 . There have been no major system replacements on the Radixact system to date; however, it is important to note it that it does not have the same workload as the clinical systems. At the time of this manuscript, it is only typically running 8-16 hr per week.
| DISCUSSION
Since its clinical inception in 2002, TomoTherapy has established itself as a versatile and robust treatment delivery system 12, 13 . TomoTherapy was conceived as a specialty machine, combining IMRT and IGRT 1 .
Currently, TomoTherapy is used to treat a wide range of plans, from static gantry 3D radiation therapy to complex multitarget IMRT. This is due in part to the introduction of new features, but also because system reliability and stability have increased over time. As expected, the addition of the DCS has improved daily and intrafraction output stability significantly. The standard deviation in the monitor chamber daily output varies less than 0.5%. This stability allows for the delivery of longer complex treatment plans (e.g., TBI and total skin treatments 14, 15 ) without the risk of treatment interruption. The dosimetric stability and system reliability have led to greater clinical utility.
Initial testing on the Radixact system has shown to be as stable as the current clinical TomoHDA systems. Sophisticated (and consequently long duration) plans can be delivered with the same level of dosimetric confidence. Moreover, these plans can be delivered faster due to the increased dose rate. With the nominal dose rate increased from 850 cGy/min to 1000 cGy/min, plans with the similar optimization parameters (jaw width, pitch, and modulation factor) The service record history does not cover the complete duration of this output and energy study due to limited availability of records for the HiArt systems.
can be delivered faster. This is because the gantry speed is set after the optimal fluence for the given parameter set is determined. The gantry speed is fixed in TomoTherapy. There is a sharp contrast in component replacement between the Hi-Art and latest generation TomoTherapy treatment systems.
Although we have highlighted the two most significant factors (DCS and FTL), numerous other incremental improvements were made across the gantry to improve overall system reliability. These improvements range from a newer magnetron design and RF feedback, waveguide design, and injector control assembly, all the way to temperature control systems and water flow rate management. All of these components can affect dosimetric stability, the lifetime of the major system components, and system uptime. introduction of DCS has also led to improved reliability. Proof of equivalent energy and output stability on the Radixact system as monitored with a variety of metrics was presented, and found to be consistent with existing systems. Confidence in the overall dosimetric stability of the Radixact delivery system is important as potential advances of a higher dose rate system can only be realized with a stable system.
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